Managing dyspepsia without alarm signs in primary care: New national guidance for England and Wales

Alimentary Pharmacology and Therapeutics

Volumn 21, Issue 9, 2005, Pages 1135-1143

  Mason, J M ^a   Delaney, B ^b   Moayyedi, P ^c   Thomas, M ^d   Walt, R ^e  

^a DURHAM UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c MCMASTER UNIVERSITY   (Canada)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; ANTACID AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; NON PRESCRIPTION DRUG; PROKINETIC AGENT; PROTON PUMP INHIBITOR;

AGE; ANAMNESIS; ARTICLE; BARRETT ESOPHAGUS; CARCINOMA; COST EFFECTIVENESS ANALYSIS; DYSPEPSIA; ENDOSCOPY; EVIDENCE BASED MEDICINE; HELICOBACTER PYLORI; LIFESTYLE; PEER REVIEW; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SELF CARE; SYMPTOMATOLOGY; UNITED KINGDOM;

AGED; DELIVERY OF HEALTH CARE; DYSPEPSIA; ENDOSCOPY, GASTROINTESTINAL; ENGLAND; FEMALE; HEALTH POLICY; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES; PRIMARY HEALTH CARE; REFERRAL AND CONSULTATION; WALES;

EID: 18444389964     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02445.x     Document Type: Article

References (33)

1. North of England Dyspepsia Guideline Development Group. Dyspepsia: Managing Dyspepsia in Adults in Primary Care. Centre for Health Services Research, Report No. 112. Newcastle UK: University of Newcastle, 2004.
2. Anonymous. Management of dyspepsia: report of a working party. Lancet 1988; 1: 576-9.
3. Anonymous. Dyspepsia Management Guidelines. BSG Guidelines in Gastroenterology, 1996.
4. Edenholm M, Gustavsson R, Jansson O, et al. Endoscopic findings in patients with ulcer-like dyspepsia. Scand J Gastroenterol Suppl 1985; 109: 163-7.
5. Adang RP, Ambergen AW, Talmon JL, Hasman A, Vismans JF, Stockbrugger RW. The discriminative value of patient characteristics and dyspeptic symptoms for upper gastrointestinal endoscopic findings: a study on the clinical presentation of 1.147 patients. Digestion 1996; 57: 118-34.
6. Hansen JM, Bytzer P, de Muckadell OBS. Management of dyspeptic patients in primary care - value of the unaided clinical diagnosis and of dyspepsia subgrouping. Scand J Gastroenterol 1998; 33: 799-805.
7. Talley NJ, Weaver AL, Tesmer DL, Zinsmeister AR. Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology 1993; 105: 1378-86.
8. McCormick A, Fleming D, Charlton J. Morbidity Statistics in General Practice: Fourth National Study 1991-1992. Series MB5 No 3. London: HMSO, 1995.
9. Department of Health (a). Prescription Cost analysis: England 2001, 2002. Available at: http://www.dh.gov.uk/ (search for 'Prescription Cost Analysis England 2001').
10. Department of Health. Reference Costs: England 2001. Available at: http://www.dh.gov.uk/ (search for 'NHS reference costs 2001').
11. Mintel International Group Ltd. Gastro-intestinal Remedies - UK. November 2002. http://reports.mintel.com/ (search for 'Gastro-intestinal Remedies - UK).
12. Pagliari CP, Grimshaw JM, Eccles M. The potential influence of small group processes on guideline development. J Eval Clin Prac 2001; 7: 165-73.
13. Meiineche-Schmidt V, Jorgensen T. Alarm symptoms in patients with dyspepsia: a three year prospective study from general practice. Scan J Gastroenterol 2002; 37: 999-1007.
14. Numans ME, van der Graaf Y, de Wit NJ, de Melker RA. How useful is selection based on alarm symptoms in requesting gastroscopy? Scan J Gastroenterol 2001; 36: 437-43.
15. Kapoor N, Bassi A, Sturgess R, Bodger K. Predictive value of alarm features in patients referred to a rapid access upper gastrointestinal cancer service. Gastroenterology 2003; 124 (S1): A1247.
16. Breslin NP. Thompson ABR. Bailey RJ. et al. Gastric cancer and other endoscopic diagnoses in patients with benign dyspepsia. Gut 2000; 46: 93-7.
17. Quine MA, Bell GD, McCloy RF, Charlton JE, Devlin HB, Hopkins A. Prospective audit of upper gastrointestinal endoscopy in two regions of England: safety, staffing, and sedation methods. Gut 1995; 36: 462-7.
18. Kitchin LI, Castell DO. Rationale and efficacy of conservative therapy for gastroesophageal reflux disease. Arch of Int Med 1991; 151: 448-54.
19. Wajed SA, Streets CG, Bremner CG, DcMeester TR. Elevated body mass disrupts the barrier to gastroesophageal reflux. Arch Surg 2001; 136: 1014-8.
20. Stanciu C, Bennett JR. Smoking and gastro-oesophageal reflux. BMJ 1972; 3: 793-5.
21. Chattopadhyay DK, Grcaney MG, Irvin TT. Effect of cigarette smoking on the lower oesophageal sphincter. Gut 1977; 18: 833-5.
22. Kahrilas PJ, Gupta RR. Mechanisms of acid reflux associated with cigarette smoking. Gut 1990; 31: 4-10.
23. Vitale GC, Cheadle WG, Patel B, Sadek SA, Michel ME, Cuschieri A. The effect of alcohol on nocturnal gastroesophageal reflux. JAMA 1987; 258: 2077-9.
24. Kaufman SE, Kaye MD. Induction of gastro-oesophageal reflux by alcohol. Gut 1978; 19: 336-8.
25. Thomas FB, Steinbaugh JT, Fromkes JJ, Mekhjian HS, Caldwell JH. Inhibitory effect of coffee on lower esophageal sphincter pressure. Gastroenterology 1980; 79: 1262-6.
26. Wendl B, Pfeiffer A, Pehl C, Schmidt T, Kaess H. Effect of decaffeination of coffee or tea on gastro-oesophageal reflux. Aliment Pharmacol Ther 1994; 8: 283-7
27. Wright LE, Castell DO. The adverse effect of chocolate on lower esophageal sphincter pressure. Am Jo Dig Dis 1975; 20: 703-7.
28. Murphy DW, Castell DO, Chocolate and heartburn: evidence of increased esophageal acid exposure after chocolate ingestion. Am J Gastroenterol 1988; 83: 633-6.
29. Holloway RH, Lyrenas E, Ireland A, Dent J. Effect of intraduodenal fat on lower oesophageal sphincter function and gastro-oesophageal reflux. Gut 1997; 40: 449-53.
30. Roberts DM. Chronic gastritis, alcohol, and non-ulcer dyspepsia. Gut 1972; 13: 768-74.
31. van Pinxteren B, Numans ME, Bonis PA, Lau J. Short-term treatment with proton pump inhibitors. H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and encloscopy negative reflux disease. The Cochrane Database of Systematic Reviews 2004. Issue 3. Art. No.: CD002095. DOI: 10.1002/14651858.CD002095.pub2.
32. Moayyedi P, Soo S, Deeks J, Delaney B, Innes M, Forman D. Pharmacological interventions for non-ulcer dyspepsia. The Cochrane Database of Systematic Reviews 2005: Issue 1. Art. No.: CD001960. DOI: 10.1002/14651858.CD001960.pub2.
33. Chiba N, Thompson ABR, Barkun AN. et al. The Rome II definition of dyspepsia does not exclude patients with GERD in primary care. Gastroenterology 2003: 124 (S2) A1572.